
Entaliv 0.5mg Tablet
Salt Composition: Entecavir
Expiry Date: 01/2028
Inclusive of all taxes
30 Tablet in Bottle
About The Product
Hepatitis B, Liver infection
Entaliv 0.5mg Tablet is a prescription-based antiviral medicine used in the treatment of the hepatitis B virus. The active ingredient of Entaliv is Entecavir, which belongs to the drug class of nucleoside reverse transcriptase inhibitors (NRTIs). Entaliv is a broad-spectrum antiviral drug used to stop the replication process of HBV in individuals with chronic hepatitis B. This Tablet works by eliminating the virus from the human body.
Side Effects
- Side effects are undesirable symptoms that can result from any medical treatment.
- Like any other medicine, Entaliv 0.5mg Tablet also causes some adverse impact on the body, most of which resolve without any medical attention.
- Some common side effects include: Fever Nausea Joint pain Vomiting Fatigue Abdominal pain Poor appetite Itching Dark yellow urine & stools Jaundice Pale skin Unusual tiredness Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
- The dosage of Entaliv 0.5mg Tablet is determined by the doctor based on your health condition.
- This medication should be taken orally on an empty stomach, or it can be consumed one hour before a meal or two hours after a meal.
- In the event of an overdose, contact your doctor immediately.
How It Works
Entaliv 0.5mg Tablet is a prescription-based antiviral medicine. It works by inhibiting the synthesis of DNA, which reduces the viral load in the body.
It also suppresses the replication/ multiplication of HBV. Taking this medicine results in improved liver conditions as the inflammation reduces over time, and it further prevents liver damage.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Entaliv 0.5mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
• Go for a liver function test once you start the treatment to ensure normal functioning of the organ.
• Do not share your medicine with other people, as some medicines treat specific genotypes of Hepatitis.
• Some Hepatitis medicines are given in combination with other antiviral drugs. So, it is advised not to use them alone.
• Hepatitis medicines are also given to treat HIV/ AIDS patients in some cases. But these medicines are not the proper treatment for this disease.
• It is advised to use effective birth control methods to avoid pregnancy. Some hepatitis drugs can cause birth defects, miscarriage, or death to an unborn baby if the mother or father is using this medicine.
• It is advised to tell your doctor about all medicines (multivitamins, herbal supplements) you're taking currently before starting your course with hepatitis medicines. There are chances that many drugs can interact, and some drugs should not be used together.
FAQs
Entaliv 0.5mg Tablet is used to treat patients diagnosed with chronic Hepatitis B virus (HBV) infection.
This medicine is usually given in combination with other antiviral medicines.
Reference
1. Matthews, S.
J. (2006).
Entecavir for the treatment of chronic hepatitis B virus infection. Clinical therapeutics, 28(2), 184-203.
2. Wong, V.
W. S., Wong, G.
L. H., Yiu, K.
K. L., Chim, A.
M. L., Chu, S.
H. T., Chan, H.
Y., ... & Chan, H. L.
Y. (2011).
Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B. Journal of hepatology, 54(2), 236-242.
3. Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., ... & Kumada, H.
(2013). Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.
Hepatology, 58(1), 98-107. 4.
Rivkin, A. (2005).
A review of entecavir in the treatment of chronic hepatitis B infection. Current medical research and opinion, 21(11), 1845-1856.
5. Jin, X., Chen, Y.
P., Yang, Y. D., Li, Y.
M., Zheng, L., & Xu, C. Q.
(2012). Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.
PLoS one, 7(3), e34198.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
